• Accueil >
  • Publications >
  • Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer

Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer

1 avr. 2015The British Journal of Radiology

DOI : 10.1259/bjr.20140800

Auteurs

V Pernin, L Belin, P Cottu, P Bontemps, C Lemanski, B De La Lande, P Baumann, F Missohou, C Levy, K Peignaux, A Reynaud-Bougnoux, F Denis, A Gobillion, M Bollet, N A Vago, R Dendale, F Campana, A Fourquet, Y M Kirova